Novel & Innovative Patient-Centric High-Dose DPI for Respiratory & Systemic Indication, Cyclops

Time: 3:00 pm
day: Conference Day 2


  • New concept for dry powder inhalation with great patient benefits and high-dose capabilities
  • Currently one product marketed for CF, and in-house pipeline in development for pulmonary and systemic indications, including rescue therapies
  • Co-development of products with NCE/NBE partners, including new modalities